- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
26. The licence holder must ensure that the package leaflet of the exempt advanced therapy medicinal product shall include the following particulars—
(a)the name of the exempt advanced therapy medicinal product;
(b)the intended effect of the medicinal product if correctly used, applied, administered or implanted;
(c)where the product contains cells or tissues of human or animal origin—
(i)a statement that the product contains such cells or tissues, and
(ii)a short description of the cells or tissues and, where such cells or tissues are of animal origin, their specific origin;
(d)where the product contains a medical device or an active implantable medical device, a description of that device and, where that device contains cells or tissues of animal origin, their specific origin;
(e)any necessary instructions for use, including—
(i)the posology,
(ii)the method of use, application, administration or implantation and, if appropriate, the route of administration,
(iii)a description of symptoms of overdose,
(iv)action to be taken in the event of overdose, including any emergency procedures,
(v)action to be taken if one or more doses have been missed, and
(vi)a recommendation to consult the doctor or pharmacist for any clarification on the use of the product;
(f)where adverse reactions are known, a description of those which may occur under recommended conditions of use of the product and, if appropriate, an indication of action to be taken in such a case;
(g)an instruction that the patient report any adverse reaction not specified in the package leaflet to the doctor or pharmacist;
(h)the expiry date in clear terms and a warning against using the product after that date;
(i)any special storage precautions;
(j)a description of any visible signs of deterioration;
(k)a complete qualitative and quantitative composition;
(l)the name and address of the holder of the manufacturer’s licence; and
(m)the date on which the package leaflet was last revised.
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument without Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: